logo

Last Update

This profile was last updated on 5/25/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Thomas Unger?

Thomas F. Unger

Vice President, Research and Development

VIVIO Health Inc

HQ Phone:  (800) 470-4034

Email: t***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

VIVIO Health Inc

17 Carrick Dr. Ste 300

Hayward, California, 94542

United States

Find other employees at this company (3)

Web References(14 Total References)


Leadership - VIVIO Health, Inc

Thomas F. Unger, PhD
VP, Research & Development Thomas is a healthcare innovator, strategist and change agent. Before VIVIO Health, he served Pfizer in a number of senior roles including head of strategy for Pfizer's Biotherapeutics and Bioinnovation Center and the Worldwide Development Organization. There, he initiated innovative efforts spanning business strategy, operational change and clinical development programs. Prior to Pfizer, Thomas held a number of senior strategic advisory positions at Aperion Partners, MTM Advisors, Wood Mackenzie and PA Consulting Group. Thomas is cofounder of BioLogic Technologies, Miragen and most recently Naia Pharmaceuticals. He also cofounded MIT's NEW Drug Development ParaDIGmS (NEWDIGS) program. He is on the advisory board of a number of companies and non-profit organizations developing innovative products, services and solutions across healthcare.


Bullet Biotechnology Team

Thomas Unger, PhDStrategic Advisor


Thomas Unger, PhD

Thomas Unger, PhD Strategic Advisor
Dr. Unger is the Chief Strategy Officer of Naia Limited, a drug development company he co-founded in 2015. Previously, he was at Pfizer Inc. where he held a number of senior roles within the Development Operations and Worldwide Regulatory Strategy organizations. He was the head of strategy for Pfizer's Biotherapeutics and Bioinnovation Center (BBC). He joined Pfizer as a senior director in the Strategic Management Group within Pfizer Global Research and Development (PGRD) where he was a member of the Development Leadership Team and responsible for leading strategic and operational initiatives within the R&D organization. While at Pfizer, Dr. Unger was responsible for initiating several innovative efforts that spanned business strategy, operational change and clinical development programs. He also was responsible for initiating a number collaborative innovation initiatives, including co-founding MIT's NEW Drug Development ParaDIGmS (NEWDIGS) program, for which he serves as a member of the Executive Committee and senior advisor. Before joining Pfizer, Dr. Unger held a number of senior strategic advisory positions including at the investment banking firm Aperion Partners, LLC and MTM Advisors, LLC, and the management consulting firms Wood Mackenzie Limited and PA Consulting Group. He started his industry career as co-founder of a number of early- stage biotechnology companies including BioLogic Technologies and Miragen Incorporated. He serves on the advisory boards of a number of emerging biotech companies and foundations. Dr. Unger earned his Ph.D. in Biological Sciences from the California College of Medicine, University of California, Irvine and his M.B.A. from the Marshall School of Business, University of Southern California.


bigfinite

Thomas Unger, Ph.D.
Thomas Unger, Ph.D. Science Advisor Thomas has held a number of positions at Pfizer Inc., most recently within the Development Operations and Worldwide Regulatory Strategy organization. Prior to these roles, he was the Head of Strategy for Pfizer's Biotherapeutics and Bioinnovation Center (BBC). He joined Pfizer as Development Strategy Lead, Strategic Management Group (SMG) within Pfizer Global Research and Development (PGRD). While at Pfizer, Thomas was responsible for initiating a number collaborative innovation initiatives, including that as a co-founding member of MIT/NEWDIGS. He currently serves on the Advisory Boards of a number of emerging biotech companies and foundations. Thomas obtained his Ph.D. in Biological Chemistry from the California College of Medicine, University of California, Irvine.and his M.B.A. from the Marshall School of Business, University of Southern California. He currently serves on the Advisory Boards of a number of emerging biotech companies, foundations and the Center for Biomedical Innovation at MIT.


Thomas Unger, PhD

Thomas Unger, PhD Strategic Advisor
Dr. Unger is the Chief Strategy Officer of Naia Limited, a drug development company he co-founded in 2015. Previously, he was at Pfizer Inc. where he held a number of senior roles within the Development Operations and Worldwide Regulatory Strategy organizations. He was the head of strategy for Pfizer’s Biotherapeutics and Bioinnovation Center (BBC). He joined Pfizer as a senior director in the Strategic Management Group within Pfizer Global Research and Development (PGRD) where he was a member of the Development Leadership Team and responsible for leading strategic and operational initiatives within the R&D organization. While at Pfizer, Dr. Unger was responsible for initiating several innovative efforts that spanned business strategy, operational change and clinical development programs. He also was responsible for initiating a number collaborative innovation initiatives, including co-founding MIT’s NEW Drug Development ParaDIGmS (NEWDIGS) program, for which he serves as a member of the Executive Committee and senior advisor. Before joining Pfizer, Dr. Unger held a number of senior strategic advisory positions including at the investment banking firm Aperion Partners, LLC and MTM Advisors, LLC, and the management consulting firms Wood Mackenzie Limited and PA Consulting Group. He started his industry career as co-founder of a number of early- stage biotechnology companies including BioLogic Technologies and Miragen Incorporated. He serves on the advisory boards of a number of emerging biotech companies and foundations. Dr. Unger earned his Ph.D. in Biological Sciences from the California College of Medicine, University of California, Irvine and his M.B.A. from the Marshall School of Business, University of Southern California.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory